Transcription of WHO Drug Information
{{id}} {{{paragraph}}}
Example: bankruptcy
WHO Drug Information
573 WHO drug Information Vol. 31, No. 4, 2017 ContentsSafety of medicines575 Priming resource-limited countries for pharmacovigilanceNaming of medicines581 Survey about International Nonproprietary Names (INN)Safety news586 Safety warningsMiconazole oral gel ; Obeticholic acid ; Linagliptine ; Dabigatran ; Flucloxacillin ; Epoetins ; Intraocular vancomycin ; Fingolimod ; Daclizumab ; Levetiracetam ; Sodium polystyrene sulfonate ; Radium-223 dichloride 590 Known risksAmoxicillin ; Moxifloxacin ; Palivizumab ; Cladribine ; Clozapine.
WHO Drug Information Vol. 31, No. 4, 2017 576 scientific and ethical standards – including those developed by WHO, the International Council of Harmonization (ICH) and
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: